Advertisement

Klinische Manifestationen der choroidalen Neovaskularisation bei AMD

  • R. F. Spaide

Zusammenfassung

Die choroidale Neovaskularisation (CNV) präsentiert sich mit verschiedenen visuellen Symptomen und Befunden, die Hinweise auf die richtige Diagnose geben können [1–3]. Die physische Invasion von Blutgefäßen und das assoziierte zelluläre Infiltrat deformieren das retinale Gewebe. Assoziierte Leckage, Blutungen und schließlich Narbenbildung können auf die Makulafunktion erheblich beeinträchtigen. In fortgeschrittenen Stadien ist das Vorliegen einer CNV recht einfach zu erkennen, doch liegt dann oftmals bereits ein schwerer Sehverlust vor.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. [1]
    Fine SL, Berger JW, Maguire MG, Ho AC (2000) Age-related macular degeneration. N Engl J Med 342:483–92PubMedCrossRefGoogle Scholar
  2. [2]
    Jager RD, Mieler WF, Miller JW (2008) Age-related macular degeneration. N Engl J Med :2606–17Google Scholar
  3. [3]
    Fine AM, Elman MJ, Ebert JE, Prestia PA, Starr JS, Fine SL (1986) Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 104:513–4PubMedGoogle Scholar
  4. [4]
    Kahn HA, Leibowitz HM, Ganley JP, et al. (1977) The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol 106:17–32PubMedGoogle Scholar
  5. [5]
    Rosenfeld PJ, Brown DM, Heier JS, et al. (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355:1419–31PubMedCrossRefGoogle Scholar
  6. [6]
    Brown DM, Kaiser PK, Michels M, et al. (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–44PubMedCrossRefGoogle Scholar
  7. [7]
    Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Arch Ophthalmol 117:1329–45Google Scholar
  8. [8]
    Yang SS, Fu AD, McDonald HR, Johnson RN, Ai E, Jumper JM (2003) Massive spontaneous choroidal hemorrhage. Retina 23:139–44PubMedCrossRefGoogle Scholar
  9. [9]
    Lamoureux EL, Hassell JB, Keeffe JE (2004) The determinants of participation in activities of daily living in people with impaired vision. Am J Ophthalmol 137:265–70PubMedCrossRefGoogle Scholar
  10. [10]
    Lee PP, Cunningham WE, Nakazono TT, Hays RD (2009) Associations of eye diseases and symptoms with self-reported physical and mental health. Am J Ophthalmol 148:804–808.e1PubMedCrossRefGoogle Scholar
  11. [11]
    Brown GC, Sharma S, Brown MM, Kistler J (2000) Utility values and age-related macular degeneration. Arch Ophthalmol 118:47–51PubMedGoogle Scholar
  12. [12]
    Marmor MF (2000) A brief history of macular grids: from Thomas Reid to Edvard Munch and Marc Amsler. Surv Ophthalmol 44:343–53PubMedCrossRefGoogle Scholar
  13. [13]
    Augustin AJ, Offermann I, Lutz J, Schmidt-Erfurth U, Tornambe P (2005) Comparison of the original Amsler grid with the modified Amsler grid. results for patients with age-related macular degeneration. Retina 25:443–5PubMedCrossRefGoogle Scholar
  14. [14]
    Wall M, May DR (1987) Threshold Amsler grid testing in maculopathies. Ophthalmology 94:1126–33PubMedGoogle Scholar
  15. [15]
    Schuchard RA (1993) Validity and interpretation of Amsler grid reports. Arch Ophthalmol 111(6):776–80PubMedGoogle Scholar
  16. [16]
    Crossland M, Rubin G (2007) The Amsler chart: absence of evidence is not evidence of absence. Br J Ophthalmol 91:391–3PubMedCrossRefGoogle Scholar
  17. [17]
    Loewenstein A, Malach R, Goldstein M, et al. (2003) Replacing the Amsler grid: a new method for monitoring patients with agerelated macular degeneration. Ophthalmology 110:966–70PubMedCrossRefGoogle Scholar
  18. [18]
    Coscas F, Coscas G, Souied E, Tick S, Soubrane G (2007) Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 144:592–9PubMedCrossRefGoogle Scholar
  19. [19]
    Goldstein M, Loewenstein A, Barak A, et al. (2005) Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 25:296–303PubMedCrossRefGoogle Scholar
  20. [20]
    Achard OA, Safran AB, Duret FC, Ragama E (1995) Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol 120(3):322–9PubMedGoogle Scholar
  21. [21]
    Alster Y, Bressler NM, Bressler SB, et al. (2005) Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology 112:1758–65PubMedCrossRefGoogle Scholar
  22. [22]
    Fujii GY, De Juan E Jr, Humayun MS, Sunness JS, Chang TS, Rossi JV (2003) Characteristics of visual loss by scanning laser ophthalmoscope microperimetry in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Am J Ophthalmol 136:1067–78PubMedCrossRefGoogle Scholar
  23. [23]
    Gass JD, Agarwal A, Lavina AM, Tawansy KA (2003) Focal inner retinal hemorrhages in patients with drusen: an early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 23:741–51PubMedCrossRefGoogle Scholar
  24. [24]
    Tolentino MJ, Miller JW, Gragoudas ES, et al. (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820–8PubMedGoogle Scholar
  25. [25]
    Grossniklaus HE, Gass JD (1998) Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol 126:59–69PubMedCrossRefGoogle Scholar
  26. [26]
    Sawa M, Ober MD, Spaide RF (2006) Autofluorescence and retinal pigment epithelial atrophy after subretinal hemorrhage. Retina 26:119–20PubMedCrossRefGoogle Scholar
  27. [27]
    Spaide RF, Goldbaum M, Wong DW, Tang KC, Iida T (2003) Serous detachment of the retina. Retina 23:820–46PubMedCrossRefGoogle Scholar
  28. [28]
    Ting TD, Oh M, Cox TA, Meyer CH, Toth CA (2002) Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. Arch Ophthalmol 120:731–7PubMedGoogle Scholar
  29. [29]
    Spaide RF (2009) Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in agerelated macular degeneration. Am J Ophthalmol 147:644–52PubMedCrossRefGoogle Scholar
  30. [30]
    Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15:100–10PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • R. F. Spaide
    • 1
  1. 1.Vitreous-Retina-Macula Consultants of New YorkNew YorkUSA

Personalised recommendations